Article Details
Retrieved on: 2022-09-27 22:20:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Developmental-stage biopharma company Silo Pharma Inc. (NASDAQ: SILO) announced the pricing of an underwritten public offering of 1000000 shares ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here